Durable medical equipment billed through a pharmacy, canes, walkers, diabetic testing supplies, and similar items, answers to a different compliance framework than the pharmacy's prescription drug claims. A pharmacy that fills and bills these claims without meeting the DMEPOS supplier standards codified at 42 CFR 424.57, including proof of delivery, faces overpayment demands, extrapolated recoupment, and audit exposure that reaches well beyond the disputed line items.
Separate Supplier Enrollment Under 42 CFR 424.57
A pharmacy cannot bill Medicare for durable medical equipment on the strength of its retail pharmacy enrollment alone. Under 42 CFR 424.57(c)(22), a supplier of DMEPOS items must hold accreditation from a CMS-approved accrediting organization covering the specific product categories it bills, separate from the pharmacy licensure and PBM network credentialing already in place. CMS then issues a distinct DMEPOS supplier number under 42 CFR 424.57(b)(2), and the regulation limits CMS to issuing only one supplier number per location. That separate enrollment track, administered through the National Supplier Clearinghouse rather than through a PBM network, is the reason a DME claim billed through a pharmacy's system answers to a different regulator than the prescriptions filled at the same counter.
Proof of Delivery and Facility Standards
42 CFR 424.57(c)(12) makes the supplier responsible for delivering the covered item to the beneficiary and for maintaining proof of delivery. The Medicare Program Integrity Manual builds on that standard, requiring a signed and dated delivery document when the supplier delivers the item directly, or delivery service tracking records confirming the date and recipient when a shipping carrier is used. Suppliers must retain that documentation, along with the underlying claim file, for seven years from the date of service and produce it on request during a Medicare or PBM audit. 42 CFR 424.57(c)(7) separately requires the supplier to maintain a practice location of at least 200 square feet that is accessible to the public and to CMS, post a visible sign and hours of operation, and set aside space for storing business records, and 42 CFR 424.57(c)(8) requires the supplier to permit on-site inspections by CMS, the National Supplier Clearinghouse, or their agents. Many of the documentation gaps that surface in a DME record trace back to the same signature and dating problems Health Law Alliance addresses in signature log findings in a pharmacy audit, only applied to a delivery slip instead of a prescription log.
Why These Claims Draw Separate Audit Review
Because a DME claim runs through a distinct supplier number and accrediting body, it does not travel through the review channel used for the prescription drug claims a PBM examines during a routine PBM audit. A pharmacy can pass its PBM's invoice reconciliation audit on the drug side of the business and still face a Medicare DME MAC or National Supplier Clearinghouse review of the same billing period on the equipment side, each with its own documentation standard and its own recoupment exposure. Where a sample of denied DME claims gets extrapolated across a full claims universe, the resulting demand can dwarf the value of the items at issue, the dynamic Health Law Alliance has documented in what a PBM audit really costs. A pharmacy that treats a DME finding as a footnote to its PBM audit risks missing the separate audit appeal deadlines that apply to the DME claim, deadlines that can operate on the same kind of fixed clock we describe in CVS Caremark audit appeals, where missing a submission window forecloses the appeal entirely.
Resolving a PBM audit does not resolve a pharmacy's DME exposure. The two claims run on separate clocks with separate consequences.
Why Early Legal Counsel Is Critical
It is critical that pharmacy owners engage healthcare defense counsel as soon as a DME claim is flagged, whether the notice comes from the pharmacy's PBM, a Medicare DME MAC, or the National Supplier Clearinghouse. Early counsel can confirm which audit track actually governs the claim at issue, assemble the proof of delivery and accreditation record before a response deadline runs, and prevent a documentation gap on the equipment side from being read into the pharmacy's broader PBM relationship. A DME finding that goes unanswered can support both a recoupment demand and a network termination notice from the same PBM, even when the underlying prescription drug claims were never in question. Waiting until a final demand or a termination letter arrives narrows the options that were available when the delivery record was first requested.
How Health Law Alliance Can Help
Health Law Alliance represents pharmacies in DME billing audits and the PBM and Medicare disputes that follow, including proof of delivery findings, supplier standard deficiencies, and extrapolated recoupment demands, as part of the firm's PBM audit defense practice. If your pharmacy is facing a DME claim finding and needs its delivery and accreditation records organized into a record CMS or a PBM will credit, contact us for a free, confidential consultation.
